AstraZeneca CEO says Summit's drug could drive new cancer treatments after $2 billion investment

8 minutes ago

Russian lab worker dies amid plague reports. Here's what we know

8 minutes ago

Russia hospitalizes almost 200 people after death from plague: Reports

8 hours ago

BioMarin reports five-year Pompe disease data showing durable motor function

3 days ago

Why Lilly and Novo are betting on amylin to power new obesity drugs after GLP-1s

3 days ago

Big Pharma's China deal spree grows with latest tie-up worth up to $7.8 billion

3 days ago

De-risking rare disease drug development

3 days ago

Micron drops despite 'a great quarter.' Why Cramer is sticking with the stock

4 days ago

$942 million: Insurer points finger at AI as suspect hospital charges appear

4 days ago

Grindr expands beyond dating with $250 million PurposeMed acquisition

4 days ago

Eli Lilly says closely watched combo obesity regimen boosts weight loss in trial

4 days ago

Novo's Wegovy pill improves weight loss after people switch from injections

5 days ago

White House moves to block $810 million in funding through pocket rescission

9 days ago

Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s

10 days ago

NIH cuts delayed a cancer trial. Patients lost time they didn't have

10 days ago

Why we like Starbucks' latest turnaround move — plus, two more wins for Eli Lilly

11 days ago

Novo's new strategy hinges on something it can't manufacture: investor trust

11 days ago

Trump administration removes around 760,000 Obamacare enrollments

11 days ago

Eli Lilly CEO says 700,000 seniors have started GLP-1s after Medicare coverage

13 days ago

Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo

14 days ago

Why more companies are fighting over beauty, health and wellness spending

14 days ago

Mitch McConnell returns to Senate after three-month health absence

20 days ago

Athletes with autism take center court at the US Open

21 days ago

Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' strategy

21 days ago

Record U.S. cyclosporiasis outbreak is over, CDC says

24 days ago

A rapid-fire update on our 33-stock portfolio, including 6 stocks to buy now

24 days ago

Rare disease is taking his vision. A gene therapy could help — if he can get it

25 days ago

Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead

26 days ago

'Patients pay the tariff': Swiss pharma CEO warns of Trump's generic drug tariff threat

27 days ago

AstraZeneca's COPD drug shows late-stage trial wins, boosts blockbuster hopes

27 days ago

Pharma major Novartis falls 10% after three drug trial setbacks

27 days ago

Cholesterol drug setback casts doubt over multibillion-dollar race

27 days ago